Researchers discover how brain cells may be hardwired for vulnerability to deadly childhood brain tumour
A clearer understanding of how brain tumours originate during brain development is paving the way for improved therapies against pediatric high-grade gliomas, the leading cause of cancer-related deaths in children and young adults.
Happy first anniversary to the Quebec SmartCare Consortium!
Led by the Opal group at the RI-MUHC, the consortium has already made advances in data infrastructure and governance, as well as improving...
$2 million USD to investigate new approaches for prostate cancer treatment
RI-MUHC researcher David P. Labbé and a team of international collaborators will investigate the mechanisms...
RI-MUHC and McGill awarded $5.1 million for infectious disease research
A new grant from the Canada Foundation for Innovation will invest in leading edge Containment Level 3...
Helping young adults achieve type 2 diabetes remission
In a collaboration with British researchers, Dr. Kaberi Dasgupta is leading a clinical trial that combines supervised exercise with meal...
The 2022 RI-MUHC Annual Report is online!
An invitation from Dr. Rhian Touyz
Quebec study on long COVID seeking participants
Purpose is to understand post-COVID symptom evolution and impact on patients’ lives
Big start for the Canadian Mother-Child Collaborative Training Platform – CAMCCO-L
CAMCCO-L is the first Canadian platform for interdisciplinary training in perinatal research on medications...
Perception is everything when it comes to the heart
McGill startup is developing an innovative mixed reality platform to support surgeons
Early and mid-career scientists at the RI-MUHC launch an organization for professional support
The newly created EArly and mid-CAreer REsearchers network (EACARE) will promote networking...